AstraZeneca Pharma shares tumble over 3% after company halts coronavirus vaccine trial

Shares of drug firm AstraZeneca Pharma, closed over 3 percent lower on Wednesday after the company paused its COVID-19 vaccine study following a participant's unexplained illness. The company's stock had tumbled 13.40 percent to Rs 3,650 during the day on the BSE. It later pared most of the losses closed 3.34 percent lower at Rs 4,074.15. On the NSE, the scrip closed 3.80 percent lower at Rs 4,070.